PDT Partners, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$237,000
-79.0%
6,000
-78.6%
0.04%
-58.1%
Q4 2021$1,126,000
+22.0%
28,002
+23.4%
0.09%
+30.3%
Q3 2021$923,000
-59.2%
22,701
-81.9%
0.07%
-63.1%
Q1 2020$2,260,000
+30.2%
125,603
+28.3%
0.18%
+67.3%
Q4 2019$1,736,000
+26.6%
97,934
+10.8%
0.11%
+32.1%
Q3 2019$1,371,000
-9.7%
88,4000.0%0.08%
-10.0%
Q2 2019$1,519,000
+6.7%
88,400
-0.0%
0.09%
+12.5%
Q1 2019$1,424,000
-59.6%
88,431
-63.3%
0.08%
-59.4%
Q4 2018$3,524,000
-25.5%
240,880
-7.5%
0.20%
+0.5%
Q3 2018$4,732,000
-20.4%
260,444
-26.1%
0.20%
-13.3%
Q2 2018$5,943,000
-14.2%
352,300
-0.3%
0.23%
-3.4%
Q1 2018$6,923,000
-16.9%
353,389
-14.0%
0.23%
-3.3%
Q4 2017$8,327,000
+1167.4%
411,019
+1312.6%
0.24%
+1323.5%
Q2 2015$657,000
+33.0%
29,096
-25.2%
0.02%
+41.7%
Q1 2014$494,00038,8990.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders